NCT06430437 2026-01-21A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 MutationsJiangsu HengRui Medicine Co., Ltd.Phase 3 Recruiting300 enrolled
NCT07171606 2025-12-18A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer(NSCLC) PatientsShenyang Sunshine Pharmaceutical Co., LTD.Phase 2 Recruiting240 enrolled